Loading…

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population

BACKGROUND: Irritable bowel syndrome (IBS) is highly prevalent worldwide but mechanisms for healthcare seeking behaviours in this patient group are poorly understood. OBJECTIVE: To describe healthcare utilization and identify factors associated with seeking healthcare amongst IBS subjects in the gen...

Full description

Bibliographic Details
Main Authors:	Tornkvist, Navkiran T., Aziz, Imran, Whitehead, William E., Sperber, Ami D., Palsson, Olafur S., Hreinsson, Jóhann Pall, Simrén, Magnus, Törnblom, Hans
Format:	Online Article Text
Language:	English
Published:	John Wiley and Sons Inc. 2021
Subjects:	Neurogastroenterology
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672084/ https://www.ncbi.nlm.nih.gov/pubmed/34599559 http://dx.doi.org/10.1002/ueg2.12153

Similar Items

Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study
by: Frändemark, Åsa, et al.
Published: (2023)

Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education
by: Simons, Julia, et al.
Published: (2022)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
by: Melchior, Chloé, et al.
Published: (2022)

European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations
by: Tornkvist, Navkiran T., et al.
Published: (2022)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
by: Melchior, Chloé, et al.
Published: (2022)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
by: Jabbar, Karolina S, et al.
Published: (2021)

Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
by: Huang, I‐Hsuan, et al.
Published: (2022)

Constipation: Prevalence in the Portuguese community using Rome IV—Associated factors, toilet behaviours and healthcare seeking
by: Caetano, Ana Célia, et al.
Published: (2022)

Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome
by: Henström, Maria, et al.
Published: (2018)

Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice
by: Simren, Magnus, et al.
Published: (2017)

Epithelial expression and function of trypsin-3 in irritable bowel syndrome
by: Rolland-Fourcade, Claire, et al.
Published: (2017)

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
by: Vasant, Dipesh H, et al.
Published: (2020)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2014)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
by: Weerts, Zsa Zsa R. M., et al.
Published: (2021)

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
by: Tooth, David, et al.
Published: (2014)

Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies
by: McPherson, Zachary E., et al.
Published: (2021)

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
by: Akbar, A, et al.
Published: (2008)

Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study
by: Seeling, Katharina Sophie, et al.
Published: (2023)

Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome
by: van Assen, Tijmen, et al.
Published: (2012)

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
by: Lövdahl, Jenny, et al.
Published: (2022)

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
by: McEvoy, Mark A., et al.
Published: (2021)

Gastric emptying rate and relevance for symptoms
by: Törnblom, Hans
Published: (2023)

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
by: Noble, Hithin, et al.
Published: (2022)

Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia
by: Kanazawa, Motoyori, et al.
Published: (2015)

Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
by: Everitt, Hazel Anne, et al.
Published: (2019)

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
by: Savarino, Edoardo, et al.
Published: (2022)

Irritable Bowel Syndrome
by: Farup, Per G., et al.
Published: (2012)

Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
by: Eccles, Jessica Anne, et al.
Published: (2020)

Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome
by: Algera, Joost P., et al.
Published: (2022)

Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar
by: Kovács, Dénes Botond, et al.
Published: (2022)

Global prevalence and burden of meal-related abdominal pain
by: Colomier, Esther, et al.
Published: (2022)

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
by: Wauters, Lucas, et al.
Published: (2021)

Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson's disease and chronic constipation
by: Su, Andrew, et al.
Published: (2016)

European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus
by: Hammer, Heinz F., et al.
Published: (2021)

Ex vivo study of human visceral nociceptors
by: McGuire, Cian, et al.
Published: (2018)

Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity
by: Castro Tejera, Valeria, et al.
Published: (2022)

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
by: Matsueda, Kei, et al.
Published: (2011)

Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus
by: Tsuchida, Yasuaki, et al.
Published: (2010)

Mechanisms of activation of mouse and human enteroendocrine cells by nutrients
by: Symonds, Erin L, et al.
Published: (2015)

Randomised controlled trial of mesalazine in IBS
by: Barbara, Giovanni, et al.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_icum3ietib83g0gmiofkbc1lti